Señales en vivo de CERT | Maximiza tus Ganancias con Getagraph.com

VENDER 107686 min ago

@ $17.66

Emitido: 14 feb 2024 @ 13:37

Retorno: -6.17%

Señal anterior: feb 14 - 12:03

Señal anterior: Comprar

Retorno: 1.15 %

Live Chart Being Loaded With Signals

Commentary (26 abr 2024 @ 16:00):

Stats
Volumen de hoy	321 644
Volumen promedio	527 866
Capitalización de mercado	2.65B
EPS	$0 ( 2024-02-29 )
Próxima fecha de ganancias	( $0.100 ) 2024-05-07
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-47.34
ATR14	$0.0120 (0.07%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-01	Feehery William F	Buy	124 779	Restricted Stock Units
2024-04-02	Smith Patrick F	Sell	5 264	Common Stock
2024-04-02	Smith Patrick F	Sell	649	Common Stock
2024-04-02	Smith Patrick F	Sell	3 024	Common Stock
2024-04-02	Smith Patrick F	Sell	328	Common Stock

INSIDER POWER
30.50
Last 100 transactions
Buy: 798 344 \| Sell: 442 671

Volumen Correlación

Largo: -0.38 (neutral)

Corto: 0.63 (weak)

Signal:(54.846) Neutral

Certara, Inc. Correlación

10 Correlaciones Más Positivas
RELY	0.963
MSAC	0.958
KAII	0.953
ALTR	0.951
APXI	0.95
LMB	0.946
AEAC	0.945
ANSS	0.944
MLAI	0.944
DSEY	0.943

10 Correlaciones Más Negativas
GOOD	-0.959
CSSEP	-0.958
HALO	-0.955
CBNK	-0.952
SFST	-0.947
WASH	-0.947
WTBA	-0.946
MCBS	-0.946
UTHR	-0.946
BMRA	-0.945

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Certara, Inc. Correlación - Moneda/Commodity

-0.61
( weak negative )

-0.40
( neutral )

0.00
( neutral )

-0.22
( neutral )

0.30
( neutral )

0.64
( weak )

Certara, Inc. Finanzas

Annual	2023
Ingresos:	$354.34M
Beneficio Bruto:	$167.79M (47.35 %)
EPS:	$-0.350

FY	2023
Ingresos:	$354.34M
Beneficio Bruto:	$167.79M (47.35 %)
EPS:	$-0.350

FY	2022
Ingresos:	$335.64M
Beneficio Bruto:	$203.07M (60.50 %)
EPS:	$0.0939

FY	2021
Ingresos:	$286.10M
Beneficio Bruto:	$174.49M (60.99 %)
EPS:	$-0.0900

Financial Reports:

No articles found.

Certara, Inc.

Certara, Inc. provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access. It offers medicines to patients using biosimulation software, technology, and services to transform drug discovery and development. The company also provides related technology-enabled services to guide its customers' new drugs through the regulatory submission process and into the market. Its technology-enabled services include mechanistic biosimulation, empirical biosimulation, drug development and regulatory strategy, clinical pharmacology, model-based meta-analysis, regulatory writing and medical communications, regulatory operations, and market access. Further, company offers software, comprising mechanistic biosimulation platform, empirical PK/PD biosimulation platform, data standardization and compliance software, scientific informatics platform, clinical outcomes databases for biosimulation, authoring and management of regulatory submissions platform, and market access communication platform. The company serves biopharmaceutical companies, and academic and government institutions. It has operations in the United States, Canada, Spain, Luxembourg, Portugal, the United Kingdom, Germany, France, the Netherlands, Denmark, Switzerland, Italy, Poland, Japan, the Philippines, India, Australia, and China. Certara Inc. was founded in 2008 and is headquartered in Princeton, New Jersey.